Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 107.04B | 108.42B | 112.86B | 103.15B | 117.06B | 101.86B |
Gross Profit | 25.01B | 25.47B | 25.72B | 21.62B | 23.11B | 21.29B |
EBITDA | 9.52B | 10.48B | 11.53B | 6.96B | 6.25B | 6.31B |
Net Income | 7.37B | 7.74B | 8.12B | 6.30B | 4.68B | 5.91B |
Balance Sheet | ||||||
Total Assets | 74.57B | 74.94B | 72.32B | 65.48B | 62.29B | 58.94B |
Cash, Cash Equivalents and Short-Term Investments | 28.56B | 28.22B | 27.90B | 23.53B | 21.68B | 19.32B |
Total Debt | 5.09B | 3.05B | 2.34B | 3.66B | 3.21B | 2.70B |
Total Liabilities | 32.76B | 33.39B | 33.76B | 31.40B | 28.46B | 29.56B |
Stockholders Equity | 40.21B | 39.97B | 36.96B | 32.75B | 32.63B | 28.50B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.57B | 9.18B | 7.42B | 3.17B | 9.55B |
Operating Cash Flow | 0.00 | 9.13B | 14.41B | 10.52B | 6.74B | 11.82B |
Investing Cash Flow | 0.00 | -3.57B | -5.16B | 1.05B | -2.33B | -6.70B |
Financing Cash Flow | 0.00 | -4.97B | -6.15B | -5.57B | -58.79M | -20.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $7.72B | 7.80 | 19.00% | 3.19% | -5.90% | -11.16% | |
77 Outperform | $17.02B | 45.90 | 76.24% | ― | 7.64% | 369.79% | |
76 Outperform | $5.65B | 16.51 | 24.98% | 3.61% | 9.80% | -6.33% | |
75 Outperform | $1.54B | 30.66 | 11.97% | ― | 9.09% | 106.50% | |
66 Neutral | £1.85B | 11.29 | 6.20% | 3.10% | 0.61% | -17.57% | |
64 Neutral | $5.52B | 37.62 | -39.97% | ― | 2.18% | -32.87% | |
55 Neutral | $7.24B | ― | 17.86% | ― | -0.89% | 46.62% |